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Class B β-lactamases or metallo-β-lactamases (MBLs) require zinc ions to catalyse the hydrolysis of β-lactam antibiotics such
as penicillins, cephalosporins, carbapenems, and cephamycins. There are no clinically useful inhibitors against MBLs which are
responsible for the resistance of some bacteria to antibiotics. There are two metal-ion binding sites that have dierent zinc ligands
but the exact roles of the metal-ion remain controversial, and distinguishing between their relative importance is complex. The
metal-ion can act as a Lewis acid by co-ordination to the β-lactam carbonyl oxygen to facilitate nucleophilic attack and stabilise the
negative charge developed on this oxygen in the tetrahedral intermediate anion. The metal-ion also lowers the pKa of the directly
co-ordinated water molecule so that the metal-bound hydroxide ion is a better nucleophile than water and is used to attack the β-
lactam carbonyl carbon. An intrinsic property of binuclear metallo hydrolytic enzymes that depend on a metal-bound water both
as the attacking nucleophile and as a ligand for the second metal-ion is that this water molecule, which is consumed during hydrol-
ysis of the substrate, has to be replaced to maintain the catalytic cycle. With MBL this is reflected in some unusual kinetic profiles.
Copyright © 2008 M. I. Page and A. Badarau. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
All β-lactam antibiotics, such as penicillins (1) and
cephalosporins (2), contain the four-membered β-lactam
ring which occurs relatively rarely in nature, therefore it
is not surprising that the biological activity of these com-
pounds should be attributed to the expected enhanced chem-
ical reactivity of the β-lactam ring [1]. It was suggested early
that the antibiotic’s activity was due to the inherent strain of
the four-membered ring or to reduced amide-resonance. The
nonplanar butterfly shape of the penicillin molecule (3) was
expected to reduce amide-resonance and thus increase the
susceptibility of the carbonyl group to nucleophilic attack,
compared with normal, planar amides [1]. However, it was
shown later that there is little evidence to confirm that the
reactivity of β-lactams in penicillins and cephalosporins is
due to an unusually strained or an amide-resonance inhib-
ited β-lactam [2]. In fact, the rate of alkaline hydrolysis of the
simple β-lactam (4) is only 3-fold greater than that of (5).
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Most nucleophilic substitution reactions of β-lactams
involve initial covalent bond formation between the carbonyl
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carbon the of β-lactam and the attacking nucleophile
followed by C–N bond fission of the β-lactam (Scheme 1).
This type of reaction is a two-step process and involves
the reversible formation of a tetrahedral intermediate [1, 2].
Contrary to expectations, opening the four-membered ring
is not a facile process [3] and, indeed, in many of these
nucleophilic substitution reactions, the rate limiting step is
not the first addition step but a subsequent one which may
sometimes even be ring opening itself [1, 2, 4–8].
Another interesting dierence between nucleophilic sub-
stitution in penicillins and peptides/amides is the pre-
ferred direction of attack and the geometry of the initially
formed tetrahedral intermediate. It is usually assumed that
nucleophilic attack on the carbonyl carbon of a planar
peptide will generate a tetrahedral intermediate with the
lone pair on nitrogen anti to the incoming nucleophile,
(6), (7). Conversely, nucleophilic attack on the β-lactams of
penicillins occurs from the least hindered α-face (exo) so
that the β-lactam nitrogen lone pair is syn to the incoming
nucleophile in the tetrahedral intermediate (8) [9]. This
has obvious consequences for the placement of catalytic
groups—particularly, if catalysis involves coordination to
metal-ions [10].
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2. β-LACTAMASES
It is more than sixty years since β-lactams were first
introduced into clinical practice, but their therapeutic
importance remains extremely high and they account for
around half of total antibiotic prescriptions [11]. Given
the rapid replication rates of bacteria against this selective
pressure, it is not surprising that mechanisms of resistance
continue to evolve and spread amongst pathogenic bacteria.
Although there are several mechanisms of β-lactam resis-
tance including modification of the target (transpeptidases),
reduction in permeability, and eux of the antibiotic, the
major reason for resistance is antibiotic inactivation by
the action of a variety of β-lactamases that are found
in a large number of clinically important pathogens [12–
14]. This number presently exceeds 500 and is growing
(http://www.lahey.org/studies/).
β-Lactamases catalyse the hydrolysis of the β-lactam of
penicillins (1) and cephalosporins (2) to give the ring opened
and bacterially inert β-amino acid (Scheme 2) [15].
The main mechanistic division of β-lactamases is into
serine enzymes and zinc enzymes [15]. The former have
an active site serine residue and the catalytic mechanism
involves the formation of an acyl-enzyme intermediate. The
metallo enzymes appear to involve coordination of the
substrate and intermediates to the active site metal-ion.
On the basis of their amino acid sequences, the serine β-
lactamases are subdivided into three classes: A, C, and D,
whereas the class B β-lactamases consist of the zinc enzymes
[15].
3. METALLO β-LACTAMASES
Class B β-lactamases or metallo-β-lactamases (MBLs)
require zinc-ions to catalyse the hydrolysis of β-lactams and
have no sequence or structural homology to the serine β-
lactamases. They exhibit a broad spectrum substrate profile
catalysing the hydrolysis of a wide range of β-lactam antibi-
otics including penicillins, cephalosporins, carbapenems,
cephamycins, and even some mechanism-based inhibitors of
class A β-lactamases [16]. The first metallo-β-lactamase to be
discovered was produced by an innocuous strain of Bacillus
cereus, but in the last 20 years, MBL-mediated resistance
has appeared in several pathogenic strains and is being
rapidly spread by horizontal transfer, involving both plasmid
and integron-borne genetic elements [17]. MBLs represent
a huge potential clinical threat to the β-lactam antibiotic
therapy as presently there are no clinically useful inhibitors
for them.
MBLs can be divided in three subclasses: subclass B1,
B2, and B3 based on their aminoacid sequences, substrate
profile, and metal-ion requirement [18, 19]. Subclass B1 is
the largest and contains several well-studied β-lactamases:
BCII from Bacillus cereus, CcrA from Bacteroides fragilis,
IMP-1, SPM-1 from Pseudomonas aeruginosa, and BlaB from
Cryseobacterium meningosepticum. These enzymes eciently
catalyse the hydrolysis of a wide range of substrates such as
penicillins, cephalosporins, and carbapenems. BCII catalyses
the hydrolysis of penicillins at significantly higher rates than
cephalosporins and carbapenems, but CcrA does not show
this preference, although both enzymes exhibit lower Km
values for cephalosporins [20].
The most common representatives of subclass B2 are
CphA from Aeromonas hydrophila and ImiS from Aeromonas
veronii, which preferentially hydrolyze carbapenems, for
example, imipenem and meropenem, but have poor activity
against penicillins and cephalosporins [20, 21]. Finally,
subclass B3 contains the only known tetrameric zinc β-
lactamase, the L1 enzyme from Stenotrophomonas mal-
tophilia, and the monomeric FEZ-1 from Legionella gor-
manii. Both enzymes hydrolyze a wide range of β-lactam
antibiotics [22, 23] with L1 having higher catalytic rate
constants (kcat) for penicillins compared with FEZ-1, which
shows higher kcat values for cephalosporins. Generally, the
Km values are smaller for L1 than for FEZ-1. However,
mutation of a methionine residue in L1, which is important
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for the subunit interaction, gives a monomeric enzyme with
significantly higher Km values and, except for nitrocefin,
smaller kcat values compared with the wild-type tetramer
[24].
3.1. The number of zinc-ions
A major problem with understanding the mechanism of
MBLs is the number of zinc-ions required for catalysis,
which has been addressed by studying MBLs under both
equilibrium and kinetic conditions. The crystal structures
of several MBLs have been determined by X-ray diraction
and they all show a similar αβ/βα sandwich fold, which was
first seen with MBLs [25], but since recognised in other
enzymes, such as glyoxalase II, aryl sulfatase, and cAMP
phosphodiesterase, which have now become members of
the MBL fold superfamily [26]. The active site of MBLs is
situated at the bottom of a wide shallow groove between two
β-sheets and has two potential zinc-ion binding sites at the
active site, often referred to as sites 1 and 2 [27–29]. The
zinc ligands in the two sites are not the same and are not
fully conserved between the dierent MBLs. Table 1 shows
the enzyme residues involved in zinc coordination in the two
binding sites in the subclasses B1, B2, and B3 [26].
In the subclass B1, such as the Bacillus cereus enzyme
BCII, the zinc in site 1 (the histidine site or His3 site) is
tetracoordinated by the imidazole groups of three histidine
residues (116, 118, and 196) and a water molecule, Wat1.
In site 2 (or the Cys site) the metal is pentacoordinated
by His263, Asp120, Cys221, and one water molecule; the
fifth ligand at site 2 is carbonate or water, often referred to
as the apical water, or Wat2 [27, 28, 30], although this is
missing in structures with inhibitors bound [31]. The two
metal-ions are relatively close to each other, but the distance
between them varies from 3.4 to 4.4 A˚ in dierent structures
of the BCII and CcrA enzymes. Several structures of the
CcrA enzyme show a bridging water ligand between the two
metals, which is thought to exist as a hydroxide-ion [32]. In
a structure of BCII determined at pH 7.5 that contains two
zinc-ions there is also a similar bridging water molecule, but
in structures of this enzyme at lower pH this solvent molecule
is strongly associated to the zinc in site 1 [30].
The two conserved zinc binding sites in MBLs have
dierent metal-ion anities. For example, the BCII enzyme
from Bacillus cereus has very dierent dissociation constants
for the two metal binding sites. The first crystal structure,
obtained at low pH [25], indicated only one zinc-ion
bound to the histidine site, but equilibrium dialysis studies
showed two binding events, with a dissociation constant
of 0.3 µM for the first zinc-ion (Kmono) and 3 µM for the
second zinc-ion (Kbi) [33]. Later metal binding studies by
fluorescence spectroscopy using a chromophoric chelator
reported a Kmono of 0.62 nM and a Kbi of 1.5 µM [34].
As the conditions of the experiments were similar for the
two studies, the large discrepancy in Kmono may be due
to the fact that dierent strains of BCII enzyme from
Bacillus cereus were used. The dissociation constants Kmono
and Kbi have been determined from the steady state rates
of hydrolysis of imipenem in the presence of EDTA as a
metal-ion buer at dierent zinc concentrations and Kmono
was found to decrease significantly, from nM to pM, in
presence of substrate, whereas Kbi decreased only by two fold
[35]. This led to the suggestion that the monozinc enzyme
is responsible for the catalytic activity under physiological
conditions, where the concentration of the “free” Zn2+ is
in the pM or even fM region. For most substrates, the
reported catalytic activity of the monozinc BCII was about
two fold lower than that of the binuclear enzyme. Conversely,
the other class B1 enzyme, CcrA from Bacteroides fragilis,
binds both zinc-ions very tightly [36]. Despite the very close
similarity with BCII, CcrA has much higher anity for the
second zinc-ion, probably due to the fact that in CcrA, a
cysteine residue replaces the positively charged arginine 121
found in BCII. However, replacing Arg 121 in BCII by a Cys
shows no increase in the anity for the second zinc-ion [37].
Early kinetic studies of CcrA led to the proposal that
both the mono and the dinuclear forms of the enzyme
were catalytically active, with slightly dierent activities, at
physiological pH [38]. However, later studies showed that
only the dinuclear species was active and that the previously
observed “monozinc” CcrA was a mixture of the dizinc
and the apo (metal free) enzyme [39]. Class B2 metallo β-
lactamases are catalytically active with one bound zinc-ion
and the binding of the second zinc-ion inhibits the enzyme
noncompetitively, with a Ki of 50 µM [40]. The dissociation
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Table 1: The zinc ligands in class B β-lactamases.
Subclass Zn1 ligands Zn2 ligands
B1 His116 His118 His196 Asp120 Cys221 His263
B2 Asn116 His118 His196 Asp120 Cys221 His263
B3 His/Gln116 His118 His196 Asp120 His121 His263
constant of the first zinc-ion was found to be 7.0 and
1.2 pM in the absence and presence of substrate (imipenem),
respectively [35]. Subclass B3 MBLs, L1, and FEZ-1 bind
both metal-ions tightly, the dissociation constants are in the
nM region, and are fully catalytically active in binuclear form
[23, 41].
3.2. The catalytic role of zinc
Zinc is an essential trace element and the second most
abundant transition metal found in living sytems. Its role
in catalysis is related to its ability to participate in tight,
but readily exchangeable ligand binding and its exceptional
flexibility of its coordination number and geometry [42]. In
addition, zinc shows no redox properties and this facilitates
its evolution in living systems without the risk of oxidative
damage. Finally, its intermediate hard-soft behaviour allows
it to bind a variety of atoms, as seen, for example, in
the second binding site of class B1 MBLs which involve
nitrogen, oxygen, and sulphur as ligands. The Lewis acidity,
flexible geometry, and coordination number and the lack
of redox properties make zinc an ideal metal cofactor for
many enzymes. The small energy dierence between 4, 5
or 6 coordination geometries and the rapid exchange of the
kinetically labile zinc-bound water molecule are important
features in all zinc hydrolases including MBLs.
MBLs are a subclass of metallo-proteases and many
mechanistic considerations are applicable to both groups.
There are many potential mechanistic roles for the metal-ion
in metallo-proteases and MBLs, although they may well vary
from enzyme to enzyme [42, 43]. It is commonly suggested
that the metal-ion acts as a Lewis acid by coordination to
the peptide carbonyl oxygen giving a more electron deficient
carbonyl carbon which facilitates nucleophilic attack. The
metal-ion thus stabilises the negative charge developed on
the carbonyl oxygen of the tetrahedral intermediate anion
(Scheme 3). Many metallo-proteases have a water molecule
directly coordinated to the metal-ion which may act as the
nucleophile to attack the carbonyl carbon. Here, the role of
the metal-ion is to lower the pKa of the coordinated water
so that the concentration of metal-bound hydroxide ion is
increased relative to bulk solvent hydroxide-ion at neutral
pH and, furthermore, although this coordinated hydroxide-
ion is dierent in nature than the simple solvated ion, it
is a better nucleophile than water (Scheme 4). These two
steps shown in Schemes 3 and 4 relate to formation of
the tetrahedral intermediate and although little attention
is normally given to the mechanism of the breakdown of
the tetrahedral intermediate, C–N bond fission is the most
energetically dicult process in peptide hydrolysis. This
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could be facilitated by direct coordination of the departing
amine nitrogen to the metal-ion (Scheme 5) which is,
in fact, the mechanism adopted for the simple zinc-ion-
catalysed hydrolysis of penicillin [10]. Alternatively, a metal-
bound water could act as a general acid catalyst protonating
the amine nitrogen leaving group to facilitate C–N bond
fission (Scheme 6). Despite intense mechanistic studies, the
detailed roles of the metal-ion in metallo-proteases and
MBLs remain controversial and distinguishing between the
relative importance of the possible roles for zinc is complex.
The eective positive charge on the zinc-ion depends on
the number and nature of its ligands and for those with an
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ionisable hydrogen, zinc lowers their pKa and the ionised
ligand obviously is better at neutralising the positive charge
density on the metal. The pKa of water is 15.7, but when
bound to zinc in aqueous solution it is lowered to 9.5, but
is there evolutionary pressure to lower the pKa of the zinc-
bound water in an enzyme even further? This could be
achieved by replacing say a negatively charged carboxylate
ligand by a neutral histidine. For example, in the opposite
direction, changing the histidine bound to zinc in carbonic
anhydrase to aspartate increases the pKa of the zinc-bound
water from 6.8 to ≥ 9.6 [45]. Whether it is better to have a
higher or lower pKa metal-bound water for a faster reaction
and more ecient catalysis depends on the role of the zinc-
ion. A low pKa implies a more electron deficient metal-ion
centre which would give a better Lewis acid to stabilise the
negative charge developed on the oxyanion of the tetrahedral
intermediate. Conversely, a high pKa for the metal-bound
water implies a weaker Lewis acid and so the zinc-ion will be
less ecient at stabilising the tetrahedral intermediate. A low
pKa for the metal-bound water implies that the hydroxide-
ion resulting from ionisation is more “tightly bound” and
stabilised which, although it becomes the dominant species
even at low pH, corresponds to a more weakly nucleophilic
hydroxide-ion. For example, if the pKa of the zinc-bound
water is about 5 then the nucleophilicity of the metal bound
hydroxide-ion is only similar to that of a carboxylate anion.
If a major role of the metal-ion is to provide a better
nucleophile than water then the net eect depends on the
relative importance of concentration and the dependence
of the rate upon nucleophilicity. If the pKa is “too high”,
metal-coordinated water will be the dominant species over
the desired pH range but deprotonation will give a more
nucleophilic metal-bound hydroxide. How reactivity changes
with changing pKa and pH will depend on the susceptibility
of the rate of reaction to the basicity of the nucleophile—
the hydroxide-ion bound to the metal—as indicated by the
Bronsted βnuc value.
Sometimes it is suggested that part of the enzyme
mechanism involves general base catalysis to remove the
proton from the zinc-bound water but this only becomes
necessary if the pKa is little changed from that of bulk
water. A problem with the commonly accepted mechanism
for metallo-proteases of rate-limiting deprotonation of zinc-
bound water concerted with nucleophilic attack is the pKa
of this water. Coordination to zinc(II) generally lowers the
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pKa of water to 5–9 depending on the number and type of
other ligands. The concentration of zinc-bound hydroxide
ion is therefore quite high over the normal pH range studied.
There is little or no catalytic advantage in having a general
base to remove a proton in this pre-equilibrium step! Even
if the pKa of the zinc(II)-bound water is about 9 then 10%
of the species already exists in the fully deprotonated form
at pH 8 and 1% at pH 7. Presumably, the deprotonated
form is a much better nucleophile than the species which is
only partially deprotonated and there would be no catalytic
advantage of the general base-catalysed mechanism.
In aqueous solution, zinc is coordinated to six water
molecules and the pKa of the zinc-bound water is 9.5. How-
ever, within a protein this pKa can be changed significantly
because of the environment and directly bonded ligands to
the metal—for example, the zinc of B. cereus β-lactamase is
coordinated to three protein ligands in the zinc1 site—His
116, His 118, and His 196 and a water molecule [30]. The
reduced coordination number of four in the zinc1 site of β-
lactamase reduces the pKa to less than 6. In principle, one or
more of the imidazole residues could be ionised, the pKa for
proton loss from imidazole is similar to that of water (about
14). However, NMR evidence suggests that the imidazole of
the bound histidines are neutral [46, 47] and the most likely
group to ionise is, therefore, the bound water (Scheme 7).
One way to investigate the role of the zinc in catalysis
is to modify the pKa of the zinc-bound water by changing
the ligands or the metal-ion. If the activity of the resulting
enzyme increases as the pKa of the zinc-bound water ligand
decreases, this would suggest that a high positive charge
density on the metal-ion facilitates catalysis and that the
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zinc coordination to the carbonyl oxygen and stabilisation
of the negative charge developed on this oxygen following
nucleophilic attack is important. A lower pKa of zinc-
bound water indicates a more electrophilic zinc which is
better at stabilising negative charge giving rise to a better
catalyst. Stabilisation of the intermediate anion must be more
important than the nucleophilicity of the zinc hydroxide.
Conversely, if activity increases with increasing pKa of the
zinc-bound water, that is, increasing basicity of the of the
zinc-bound hydroxide ion, then this would indicate a greater
role for the metal-ion in controlling the nucleophilicity of
the hydroxide-ion compared with its role in stabilising the
negative charge development on the carbonyl oxygen.
The dual role of zinc in metallo-proteases, that is,
acting as a Lewis acid in polarising the carbonyl bond
and as source of nucleophilic hydroxide, requires formally
the formation of an apparently strained four-membered
ring (Scheme 8). However, this coordination occurs in
the bidentate complexes of zinc with carboxylate anions.
Monodentate complexes between zinc and a carboxylate
anion exist predominantly as the syn stereoisomer due to
the more basic syn lone pair and favourable opposition of
the C=O and O–Zn dipoles. The coordination adopted for
the syn conformation is similar to a bidentate one which is
favoured by electrostatic interactions [48].
One final point to consider for the hydrolysis of β-
lactams by metallo-β-lactamases is that if the zinc bound
hydroxide-ion is the nucleophile then it is consumed during
turnover. Consequently, regeneration of the catalyst requires
the coordination of a new water molecule to the active
site zinc. For example, if product release occurs through
displacement by water or is introduced in a separate step
following product release, deprotonation must occur to
generate a catalytically active species (Scheme 9). It is
conceivable that one of these steps may become kinetically
significant under some conditions, particularly if the water
is used both as a nucleophile and as a bridging ligand in
binuclear enzymes.
3.3. Mechanisms
Although the metal-ion requirement in MBLs catalysed
hydrolysis of β-lactam antibiotics is still a matter of debate,
catalytic mechanisms have been proposed for both the
mono- and binuclear enzymes. The first catalytic mechanism
suggested for BCII [25] (Scheme 10) was based on its
crystal structure at a resolution of 2.5
′
A˚, where only one
zinc-ion was bound to the enzyme, in the histidine site.
The main features of this mechanism are similar to those
often proposed for zinc peptidases such as carboxypeptidase
A and thermolysin. Following substrate binding, the zinc-
bound water molecule, deprotonated by the Asp120 residue,
attacks the carbonyl centre with the formation of a negatively
charged tetrahedral intermediate, which is stabilised by its
interactions with the metal-ion. The Asp120 residue donates
a proton to the nitrogen and C–N bond cleavage occurs,
followed by product dissociation from the enzyme active
site. The main disadvantage of this model is the unnecessary
step of removing a proton from the zinc-bound water as
it is already ionised, although this may be required during
turnover.
The pH-rate profile for the BCII catalysed hydrolysis of
benzylpenicillin and cephaloridine [49] was taken to indicate
that the zinc-ion-bound water has a low pKa of <5 and is
therefore fully ionised at neutral pH. Nucleophilic attack by
the metal-bound hydroxide ion on the carbonyl followed
by a proton abstraction from the Asp120 gives a dianionic
tetrahedral intermediate (Scheme 11). It was suggested that
the same aspartate residue functions as proton donor to
facilitate C–N bond fission, and either step k2 or k3 could be
rate limiting. A dianionic intermediate assists β-lactam ring
opening and generates a carboxylate anion rather than the
undissociated acid.
Based on the crystal structure of CcrA MBL from Bac-
teroides fragilis and on models of β-lactam substrates bound
in the enzyme active site, a mechanism of hydrolysis for the
dizinc enzyme has been suggested to be analogous to mecha-
nisms proposed for other binuclear metallo-hydrolases [50].
In this mechanism (Scheme 12), the bridging hydroxide-ion
is responsible for the nucleophilic attack which results in a
negatively charged intermediate stabilised by the oxyanion
hole of the enzyme. The apical water molecule bound to zinc
is optimally positioned to donate a proton to the leaving
nitrogen, and the newly formed hydroxide-ion moves to
occupy the vacated Wat1 site, followed by product disso-
ciation from the enzyme active site. The original proposal
involved zinc coordination to the β-lactam nitrogen, but this
is unlikely because of its relatively low electron density due to
amide-resonance. However, nitrogen binding to zinc is more
likely once the tetrahedral intermediate is formed because of
its increased basicity [10].
These studies used the unusual β-lactam nitrocefin as
substrate for CcrA, which, because of the chromophoric
product, allowed rapid scanning and single-wavelength
stopped-flow studies to reveal the accumulation, during
turnover, of an enzyme bound intermediate with an intense
absorbance at 665 nm [51, 52]. This was postulated to be an
enzyme intermediate in which the leaving nitrogen atom is
not protonated during the cleavage of the C–N bond and
remains negatively charged (9). The anion is stabilised by
extensive conjugation with the dinitrostyryl substituent in
the C3 position and by the zinc-ion in the second active site
and so is an atypical leaving group. Most amine anions are
very unstable and are unlikely to be expelled without N-
protonation.
S
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A similar intermediate has been observed during the
class B3 L1 enzyme-catalysed hydrolysis of nitrocefin, and,
as in the case of CcrA,its breakdown was rate-limiting [53].
However, stop-flow studies of the tryptophan fluorescence
revealed that the mechanism of nitrocefin hydrolysis by
binuclear metallo-β-lactamases may be unusual and cleavage
of the β-lactam amide bond is the rate determining step for
the breakdown of the majority of β-lactam substrates by the
L1 enzyme [54].
In contrast to these results, no accumulation of an
anionic intermediate could be detected in reactions catalysed
by BCII and the rate of substrate depletion and product
formation are similar [55]. However, for the BCII-catalysed
hydrolysis under cryoenzymological conditions, a slightly
red-shifted intermediate (440 nm) was observed, which was
suggested to be a nitrocefin-like tetrahedral intermediate
[56].
An unusual mechanism has been proposed for subclass
B2 metallo-β-lactamase CphA from Aeromonas hydrophila
based on the crystal structures of the free enzyme and
of a reaction intermediate between the enzyme and the
substrate meropenem (Scheme 13) [57]. Nucleophilic attack
is performed by a water molecule not coordinated to zinc,
but activated by general base catalysis by His118, followed
by C–N bond fission which occurs prior to nitrogen proto-
nation. This proposal uses zinc as a Lewis acid to facilitate
C–N bond fission and to stabilise the leaving group—a
mechanism proposed much earlier based on model studies
[10]—whereas most mechanisms use the zinc-ion to act
as a Lewis acid to stabilize oxyanion formation from the
β-lactam carbonyl oxygen. Rearrangement of the proposed
intermediate amine anion, whose negatively charged nitro-
gen is stabilised by an interaction with the zinc-ion, gives the
bicyclic intermediate shown (Scheme 13), which is observed
in the crystal structure, although this rearrangement may not
occur in the active site of the enzyme. A solvent molecule
replacing the water used in the nucleophilic attack protonates
the nitrogen and releases the final product.
3.4. Mutation studies with MBLs
Many mutant enzymes from the three subclasses of MBLs
have been produced and characterised. In general, the
residues substituted have been the metal ligands, those
providing the framework for orienting the metal ligands
or those thought to interact with the substrates. For BCII,
replacing the histidine residues in the first binding site with
serine resulted in decrease of catalytic activity, although
the anity for zinc was not significantly altered [58]. The
decrease in activity appeared as due to an increase in Km
which was rationalised on the basis that, in absence of a His
ligand, there is a higher degree of flexibility of the substrate
inside the catalytic site.
The replacement of the Cys221 residue with alanine or
serine in the active sites of BCII [58], CcrA [59], and IMP-
1 [60] gives a drastic decrease in the rate of hydrolysis at
low zinc concentrations, but the mutants are “reactivated”
by the addition of excess zinc, at least in case of BCII and
IMP1. It was proposed that the presence of Cys has a crucial
importance for the catalytic activity of the monozinc enzyme
but not for the dinuclear species [58].
Substituting the zinc 2 ligand Asp120 in BCII with Asn
reduces the catalytic activity by more than 100 fold, but
does not impair the binding of the second zinc-ion [58].
Although these results support the hypothesis that Asp120
plays an important role in catalysis, the significant catalytic
activity of the mutants is inconsistent with Asp playing the
role of a general base. The same amino acid substitution
in subclass B3 MBL enzyme L1 led to an average 10 fold
decrease in catalytic activity in the binuclear mutant [61]. It
is interesting that for the hydrolysis of nitrocefin, this mutant
shows an unusually large kinetic solvent isotope eect (KSIE)
of 5.36 compared with the wild type (KSIE = 2.08) and other
aspartate mutants: Asp120Cys and Asp120Ser (KSIE < 2).
It is concluded that the Asp120 residue is essential for the
catalytic activity in the orientation of the bridging group
of the L1 enzyme, in the protonation step of breakdown of
the tetrahedral intermediate, rather than in its formation
involving nucleophilic attack, as previously suggested [62].
The mutation of the second shell ligand, Arg121Cys, in
BCII gives an enzyme with a lower anity for the second
metal-ion compared to the wild type [58]. Moreover, the
electronic spectrum of the dicobalt Arg121Cys BCII mutant
is identical to that of the wild-type enzyme indicating that
the mutation has not altered the metal coordination sphere.
The catalytic activity of the mutant is only two fold lower
than that of the wild type for both the mono- and dinuclear
forms of the enzyme. The Cys104Arg mutation in CcrA led
to a binuclear enzyme with significantly decreased activity
and which, unlike the wild type, can have one bound metal-
ion removed by a chelator [39]. Presteady state kinetics
suggested a change in the rate limiting step in the hydrolysis
of nitrocefin, from nitrogen protonation in the wild type, to
C–N bond fission in the mutant, which showed a catalytic
rate constant similar to that of the dizinc BCII enzyme. The
monozinc form of the mutant showed a kcat value similar to
that of the monozinc BCII, for nitrocefin hydrolysis, with a
further decrease of the rate of C–N bond fission compared
with the dizinc mutant, but with a similar protonation rate.
Based on these observations it was concluded that both the
replacement of the arginine residue and the introduction of
the second metal-ion are evolutionary tools for accelerating
C–N bond fission in MBL catalysed hydrolysis of β-lactams.
However, an important role in lowering the energy barrier
8 Bioinorganic Chemistry and Applications
N
O
N
N
N
HO
N
H
O
L
L
L
M
B
L
L
L
M
B
L
L
L
M
OH
B
L
L
L
M
L
L
L
M B
H2O
L
L
L
M OH2
B
O−
O−
O−
O−
O−
OH−
OH−
−H+
BH+
+S
Scheme 9
O
N
R
S
O
H
H
O
N
R
S
OH
OHO
O
O NH
R
S
OH
O−
−O
O−
CO−2
CO−2
CO−2
Zn2+
Zn2+ Zn2+
His196
His118
His116
His196
His118
His116
His196
His118
His116
Asp120
Asp120
Asp120
H2O (bulk)
Scheme 10
for breaking the C–N bond must come from other enzyme
structural rearrangements, since the reciprocal, that is, the
sole replacement of the arginine by a cysteine residue and the
insertion of a second zinc-ion in BCII, only marginally (two
fold) improves the catalytic activity [55].
Another interesting mutagenesis study has been carried
out on class B2 CphA enzyme from Aeromonas hydrophila,
which is a special case of an MBL, both regarding its narrow
substrate profile and its metal-ion requirement [63]. The
Asn116 residue in site one was mutated to a histidine in an
attempt to create a B1 type first binding site; this mutation
changed the properties of the CphA enzyme towards a
broader substrate profile (characteristic to subclass B1), as
both penicillins and cephalosporins became significantly
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better substrates. Moreover, the activity of the Asn116His
mutant increased with increasing metal-ion concentration
for the hydrolysis of benzylpenicillin and cephaloridine,
as opposed to imipenem, where addition of zinc to both
the mutant and the wild type lead to noncompetitive
inhibition. The Cys221Ser and Cys221Ala mutants were
seriously impaired in their ability to bind the first zinc-ion
and were nearly completely inactive indicating a major role
for Cys221 in binding the catalytic metal-ion.
3.5. Metal ion substitution
The exchange of the spectroscopically silent zinc in zinc
enzymes with probes, such as cobalt, copper, and cadmium,
enables the study of the metal interactions in the enzyme
active site with its ligands, substrates, and inhibitors of
the metallo-enzyme using techniques such as electronic
spectroscopy, NMR, EPR, and perturbed angular correlation
(PAC) spectroscopy. The zinc of metallo β-lactamases can
be exchanged with cadmium, cobalt, and manganese to give
catalytically active enzymes. The use of a combination of
NMR and PAC spectroscopy to study cadmium binding to
B. cereus MBL has revealed a rapid intramolecular exchange
of the metal between the two sites in the monocadmium
enzyme and negative cooperativity in metal binding [64].
The enzyme inhibitor (R)-thiomandelate induces a very
strong positive cooperativity for binding the second cad-
mium cation [65].
The metal-ion environment of cobalt-substituted met-
allo β-lactamases has been studied by UV-vis spectroscopy,
NMR, and ESR. The UV-vis spectra of cobalt-substituted
class B1 metallo-β-lactamases CcrA from Bacteroidis fragilis
[36, 66] and BCII from Bacillus cereus [67, 68] show similar
features with an intense S to Co(II) ligand to metal charge
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transfer transition (LMCT) band at 340 and 348 nm and four
characteristic d-d transition bands between 500 and 650 nm.
The spectrum of Co-BCII in the visible region is also very
similar to that of Co(II) carbonic anhydrase at alkaline pH
[69], suggesting that the contributions from the His3 metal
centre dominate this part of the spectrum of Co substituted
class B1 MBLs.
On titration of monozinc BCII with Co(II), the spectrum
shows an LMCT band, but without the four ligand field
bands which suggests that zinc binds to the His3 site, while
cobalt preferentially occupies the Cys site in the hetero-
substituted CoZn-enzyme [67]. A similar discrimination
between metals in occupying the two binding sites in BCII
was noted for the CdZn-enzyme, where zinc also binds
in the His3 site and Cd to the Cys site [64]. Studies of
cobalt binding to apo BCII, using HEPES as a buer and
no added sodium chloride, showed that increasing the ratio
Co(II)/enzyme above one resulted in a decrease of the charge
transfer band at 344 nm and the appearance of an additional
charge transfer band at 383 nm. This has been explained by
the binding of a second cobalt ion to the monocobalt BCII
species and the existence of two dierent Co(II) LMCT band
positions, one for the mononuclear (344 nm) and one for the
binuclear enzyme (383 nm); this latter band disappears upon
addition of sodium chloride, accompanied by an increase
in absorbance at 344 nm, which led to the suggestion that
chloride hinders the binding of a second cobalt ion [34].
More recent data supported by NMR and EPRevidence have
shown that the band at 383 nm corresponds to a third, more
weakly bound cobalt ion that perturbs the 344 nm signal
(the Cys site), without aecting the spectral features of the
histidine site [70].
Low-temperature EPR spectra of metallo-β-lactamases
indicate the presence of high spin, but not coupled, Co(II)
ions in a rhombically distorted pentacoordination sphere in
Co-substituted BCII [68], a penta/hexacoordination envi-
ronment in Co-substituted CcrA enzyme [36], a tetra-
coordination environment for the first cobalt ion, and
penta/hexacoordination sphere for the second cobalt ion in
Co-substituted ImiS [71]. For this latter enzyme, it has been
shown by EPR that the second cobalt ion is magnetically
isolated, suggesting a distance of more than 7 A˚from the
first bound cobalt ion. Furthermore, NMR titration of
the monocobalt ImiS enzyme with Co(II) indicated that
the second cobalt ion is not bound to histidine, as the
newly observed resonances are not solvent exchangeable;
these findings were taken to indicate that the Zn1 site has
no catalytic or metal binding role in ImiS, that Zn2 site
binds the metal-ion that is required for catalysis, and a
remote, lower-anity, metal binding site is responsible for
the noncompetitive inhibition of the enzyme [72]. From
the mechanistic point of view, it has been shown by time
dependent UV-vis spectroscopy and fluorescence quenching,
using nitrocefin as a substrate, that Co-substituted L1, a
class B3 metallo-β-lactamase, probably utilises a reaction
mechanism similar to that of the native zinc enzyme [54, 73].
Rapid-freeze-quench (RFQ) EPR shows that a short-lived
intermediate is a metal-bound species, and the role of the
metal-ion in catalysis is similar for nitrocefin, cephalothin,
meropenem, and benzylpenicillin [73].
The kinetics and mechanism of hydrolysis of the B.
cereus (BcII) metallo-β-lactamase substituted with various
metal-ions have been investigated to determine the role
of the active site metal-ion [74]. The pH and metal-ion
dependence of kcat and kcat/Km for the cobalt-substituted
BcII catalysed hydrolysis of cefoxitin, cephaloridine, and
cephalexin indicate that an enzyme residue of apparent
pKa 6.3 is required in its deprotonated form for metal-
ion binding and catalysis. The kcat/Km for cefoxitin and
cephalexin hydrolysis with cadmium-substituted BcII is
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dependent on two ionising groups on the enzyme: one of
pKa1 8.7, required in its deprotonated form, and the other
of pKa2 9.3, required in its protonated form for activity.
The identity of these residues was determined from the pH-
dependence of the competitive inhibition constant, Ki, of
the Cd BcII by L-captopril which showed that the pKa1
of 8.7 corresponds to the cadmium-bound water. For the
manganese-substituted BcII, the pH-dependence of kcat/Km
for the hydrolysis of β-lactam antibiotics similarly indicated
the importance of two catalytic groups: one of pKa1 8.5 which
needs to be deprotonated and the other of pKa2 9.4 which
needs to be protonated for catalysis; the pKa1 was assigned
to the manganese-bound water [74]. Interestingly, the metal-
substituted enzymes have similar or higher catalytic activities
compared with the native zinc enzyme, albeit at pHs above 7
and, for the Co enzyme, at all pHs (Figure 1). With cefoxitin,
a very poor substrate for Zn BcII, both kcat and kcat/Km
increase with increasing pKa of the metal-bound water, in
the order Zn<Co<Mn<Cd. A higher pKa for the metal-
bound water for cadmium and manganese BCII leads to
more reactive enzymes than the native zinc BcII, suggesting
that the role of the metal-ion is predominantly to provide
the nucleophilic hydroxide, rather than to act as a Lewis acid
to polarise the carbonyl group and stabilise the oxyanion
tetrahedral intermediate [74].
Given the relatively weak binding of the second zinc in
the B. cereus (BcII) MBL and the fact that an important
ligand holding the metal-ion to the protein is the bridging
water which is consumed during the catalytic cycle of
hydrolysis, it is possible that the second metal-ion could be
lost during turnover. In fact, the kinetics of the hydrolysis
of benzylpenicillin catalysed by the cobalt substituted β-
lactamase from B. cereus (BcII) are biphasic with an initial
burst of product formation followed by a steady-state rate
of hydolysis [75]. This was interpreted as being due to a
branched kinetic pathway with two enzyme intermediate
species, ES1 and ES2, which have dierent metal: enzyme
stoichiometries. ES1 is a dicobalt enzyme intermediate and
is catalytic, but is slowly losing one bound cobalt ion during
turnover via the branching route, to give the mononuclear
and inactive enzyme intermediate ES2. The dependence
of enzyme activity on pH and metal-ion concentration
indicates that only the dicobalt enzyme is catalytically
active. The monocobalt enzyme species, formed during
the catalytic cycle, is virtually inactive and requires the
association of another cobalt ion for turnover. The dicobalt
enzyme intermediate is responsible for the direct catalytic
route, which is pH-independent between 5.5 and 9.5. The
inactivation pathway of metal-ion dissociation occurs by
both an acid catalysed and a pH-independent reaction, which
is dependent on the presence of an enzyme residue of pKa
8.9 in its protonated form and shows a large kinetic solvent
isotope eect (H2O/D2O) of 5.2, indicative of a rate limiting
proton transfer [75]. The pseudo first-order rate constant
to regenerate the dicobalt β-lactamase from the monocobalt
enzyme intermediate has a first-order dependence on cobalt
ion concentration. This unusual behaviour is attributed to
an intrinsic property of metallo hydrolytic enzymes that
depend on a metal-bound water both as a ligand for the
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Figure 1: Plot of log kcat/Km for () ZnBCII-, (•) CoBCII-, ()
CdBCII-, and (x) MnBCII-catalysed hydrolysis of cephalexin.
second metal-ion and as the nucleophile which is consumed
during hydrolysis of the substrate and so has to be replaced
to maintain the catalytic cycle [75, 76].
There remain questions regarding the necessity of the
binuclear metal centre itself: (i) are metallo-enzyme species
responsible for the physiological activity, the binuclear
one or the mononuclear one, or are they interchangeable
under certain conditions? and if so, (ii) are these changes
relevant to any other functions, apart from catalysis, such
as regulation of activity? It does seem intrinsically odd in
the binuclear enzyme that the bridging hydroxide-ion is
used as a nucleophile because of its presumed weak basicity.
Hydroxide-ion has three lone pairs, two of which are taken
up by metal-ion coordination and one of which is required
for nucleophilic attack and covalent bond formation. If this
bridging hydroxide-ion is used as the attacking nucleophile is
it activated by general base catalysis so that concerted proton
removal generates a dianionic tetrahedral intermediate?
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